Agger Mette Kirstine
Insider CIK 1722234 · TRVI Director · SCPH Director, 10% owner · IMRA Director, 10% owner · LXEO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 30,000 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 19,750 | — | $0 | 0 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2025-06-26 | 2025-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2024-06-25 | 2024-06-27 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 19,750 | — | $0 | 19,750 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2024-02-02 | 2024-02-06 | 36,000 | — | $0 | 36,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,300 | — | $0 | 17,300 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 6,124 | — | $0 | 6,124 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 478,749 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2020-03-16 | 2020-03-16 | 15,457 | — | $0 | 15,457 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 1,894,444 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,470,492 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-16 | 2020-03-16 | 187,500 | $16.00 | $3.00M | 1,432,722 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 1,245,222 | — | $0 | 1,245,222 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2019-06-18 | 2019-06-20 | 6,124 | — | $0 | 6,124 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 6,849,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 776,544 | — | $0 | 776,544 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 375,000 | $10.00 | $3.75M | 1,151,544 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2019-05-07 | 2019-05-08 | 23,684 | — | $0 | 23,684 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 6,124 | — | $0 | 6,124 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2017-11-21 | 2018-02-13 | 654,762 | $14.00 | $9.17M | 3,183,986 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion deriv | 2017-11-21 | 2017-11-21 | 7,067,945 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion deriv | 2017-11-21 | 2017-11-21 | 11,092,383 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion | 2017-11-21 | 2017-11-21 | 1,544,858 | — | $0 | 1,544,858 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion | 2017-11-21 | 2017-11-21 | 984,366 | — | $0 | 2,529,224 | SEC↗ |